Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

GABAergic dysfunction, neural network hyperactivity and memory impairments in human aging and Alzheimer’s disease
Joan Jiménez-Baladó, Teal S. Eich
Seminars in Cell and Developmental Biology (2021) Vol. 116, pp. 146-159
Open Access | Times Cited: 131

Showing 1-25 of 131 citing articles:

Neurotransmitters—Key Factors in Neurological and Neurodegenerative Disorders of the Central Nervous System
Raluca Ioana Teleanu, Adelina-Gabriela Niculescu, Eugenia Roza, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 11, pp. 5954-5954
Open Access | Times Cited: 270
Signalling cognition: the gut microbiota and hypothalamic-pituitary-adrenal axis
Jody Rusch, Brian T. Layden, Lara R. Dugas
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 117
Fast-spiking parvalbumin-positive interneurons in brain physiology and Alzheimer’s disease
Sara Hijazi, August B. Smit, Ronald E. van Kesteren
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 4954-4967
Open Access | Times Cited: 47
Neurodegenerative disorders: Mechanisms of degeneration and therapeutic approaches with their clinical relevance
Dnyandev Gadhave, Vrashabh V. Sugandhi, Saurav Kumar Jha, et al.
Ageing Research Reviews (2024) Vol. 99, pp. 102357-102357
Open Access | Times Cited: 33
Sleep disorders cause Parkinson's disease or the reverse is true: Good GABA good night
Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, Ali K. Albuhadily, et al.
CNS Neuroscience & Therapeutics (2024) Vol. 30, Iss. 3
Open Access | Times Cited: 18
Molecular Mechanisms and Therapeutic Potential of α- and β-Asarone in the Treatment of Neurological Disorders
Rengasamy Balakrishnan, Duk-Yeon Cho, In‐Su Kim, et al.
Antioxidants (2022) Vol. 11, Iss. 2, pp. 281-281
Open Access | Times Cited: 42
The GABAergic system in Alzheimer’s disease: a systematic review with meta-analysis
Giovanna Carello‐Collar, Bruna Bellaver, Pâmela C.L. Ferreira, et al.
Molecular Psychiatry (2023) Vol. 28, Iss. 12, pp. 5025-5036
Closed Access | Times Cited: 31
The hippocampus associated GABAergic neural network impairment in early-stage of Alzheimer's disease
Yuanhong Tang, Yan Yan, Jian Mao, et al.
Ageing Research Reviews (2023) Vol. 86, pp. 101865-101865
Closed Access | Times Cited: 23
The neurotransmitter puzzle of Alzheimer's: Dissecting mechanisms and exploring therapeutic horizons
Monika Sharma, Pankaj Pal, Sukesh Kumar Gupta
Brain Research (2024) Vol. 1829, pp. 148797-148797
Closed Access | Times Cited: 15
Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer’s disease
Abdallah M. Eteleeb, Brenna C. Novotny, Carolina Soriano‐Tárraga, et al.
PLoS Biology (2024) Vol. 22, Iss. 4, pp. e3002607-e3002607
Open Access | Times Cited: 12
Phasic/tonic glial GABA differentially transduce for olfactory adaptation and neuronal aging
Hankui Cheng, Chen Du, Xiao Li, et al.
Neuron (2024) Vol. 112, Iss. 9, pp. 1473-1486.e6
Closed Access | Times Cited: 9
Age-Related Synaptic Signatures of Brain and Cognitive Reserve in the Rat Hippocampus and Parahippocampal Regions
David J. Horovitz, Laura A Askins, Grace M Regnier, et al.
Neurobiology of Aging (2025) Vol. 148, pp. 80-97
Open Access | Times Cited: 1
Impaired spike-gamma coupling of area CA3 fast-spiking interneurons as the earliest functional impairment in the AppNL-G-F mouse model of Alzheimer’s disease
Luis Enrique Arroyo‐García, Arturo G. Isla, Yuniesky Andrade‐Talavera, et al.
Molecular Psychiatry (2021) Vol. 26, Iss. 10, pp. 5557-5567
Open Access | Times Cited: 51
Intake of flavonoids from Astragalus membranaceus ameliorated brain impairment in diabetic mice via modulating brain-gut axis
Xuling Li, Tingting Zhao, Junling Gu, et al.
Chinese Medicine (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 36
Synaptosome microRNAs regulate synapse functions in Alzheimer’s disease
Subodh Kumar, Erika Orlov, Prashanth Gowda, et al.
npj Genomic Medicine (2022) Vol. 7, Iss. 1
Open Access | Times Cited: 30
Somatostatin and the pathophysiology of Alzheimer’s disease
Victor N. Almeida
Ageing Research Reviews (2024) Vol. 96, pp. 102270-102270
Closed Access | Times Cited: 8
Biophysical models applied to dementia patients reveal links between geographical origin, gender, disease duration, and loss of neural inhibition
Sebastián Moguilner, Rubén Herzog, Yonatan Sanz Perl, et al.
Alzheimer s Research & Therapy (2024) Vol. 16, Iss. 1
Open Access | Times Cited: 6
A comprehensive review on the prevention and regulation of Alzheimer’s disease by tea and its active ingredients
Yi Huang, Yang Wei, Jia Xu, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 63, Iss. 30, pp. 10560-10584
Closed Access | Times Cited: 25
NLRP3–GABA signaling pathway contributes to the pathogenesis of impulsive-like behaviors and cognitive deficits in aged mice
Luying Wang, Xupeng Wang, Jin-Meng Lv, et al.
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 15
Comprehensive Review of Nutraceuticals against Cognitive Decline Associated with Alzheimer’s Disease
Edwin E. Reza-Zaldívar, Daniel A. Jacobo‐Velázquez
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35499-35522
Open Access | Times Cited: 13
An Expanded Narrative Review of Neurotransmitters on Alzheimer’s Disease: The Role of Therapeutic Interventions on Neurotransmission
Enes Akyüz, Alina Arulsamy, Feyza Şule Aslan, et al.
Molecular Neurobiology (2024)
Open Access | Times Cited: 5
Targeting galectin-3 to counteract spike-phase uncoupling of fast-spiking interneurons to gamma oscillations in Alzheimer’s disease
Luis Enrique Arroyo‐García, Sara Bachiller, Rocío Ruiz, et al.
Translational Neurodegeneration (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 12
Amelioration of olfactory dysfunction in a mouse model of Parkinson’s disease via enhancing GABAergic signaling
Xingyang Liu, Ke Wang, Xianhua Deng, et al.
Cell & Bioscience (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 12
Factors affecting the GABAergic synapse function in Alzheimer’s disease: Focus on microRNAs
Jazmin Rivera, Bhupender Sharma, Melissa M. Torres, et al.
Ageing Research Reviews (2023) Vol. 92, pp. 102123-102123
Open Access | Times Cited: 11
Firing Alterations of Neurons in Alzheimer’s Disease: Are They Merely a Consequence of Pathogenesis or a Pivotal Component of Disease Progression?
Nikolaos P. Tzavellas, Konstantinos I. Tsamis, Andreas P. Katsenos, et al.
Cells (2024) Vol. 13, Iss. 5, pp. 434-434
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top